ES2156223T3 - Ensayo inmunologico competitivo utilizando derivados de analitos complejados. - Google Patents

Ensayo inmunologico competitivo utilizando derivados de analitos complejados.

Info

Publication number
ES2156223T3
ES2156223T3 ES96100267T ES96100267T ES2156223T3 ES 2156223 T3 ES2156223 T3 ES 2156223T3 ES 96100267 T ES96100267 T ES 96100267T ES 96100267 T ES96100267 T ES 96100267T ES 2156223 T3 ES2156223 T3 ES 2156223T3
Authority
ES
Spain
Prior art keywords
analytics
complexed
derivatives
immunological test
competitive immunological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96100267T
Other languages
English (en)
Inventor
Stephan Dr Neuenhofer
Heinz-Jurgen Dr Skrzipczyk
Peter Dr Molz
Reinhard Kasmarker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg GmbH filed Critical Dade Behring Marburg GmbH
Application granted granted Critical
Publication of ES2156223T3 publication Critical patent/ES2156223T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A UN PROCEDIMIENTO PARA LA COMPROBACION DE UN ANALITO EN UN TEST DE INMUNIDAD COMPETITIVO EN PRESENCIA DE UN DERIVADO DE ANALITO, ASI COMO UN KIT PARA LA REALIZACION DEL PROCEDIMIENTO DE COMPROBACION.
ES96100267T 1995-02-09 1996-01-10 Ensayo inmunologico competitivo utilizando derivados de analitos complejados. Expired - Lifetime ES2156223T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19504198A DE19504198A1 (de) 1995-02-09 1995-02-09 Kompetitiver Immuntest unter Verwendung komplexierter Analytderivate

Publications (1)

Publication Number Publication Date
ES2156223T3 true ES2156223T3 (es) 2001-06-16

Family

ID=7753503

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96100267T Expired - Lifetime ES2156223T3 (es) 1995-02-09 1996-01-10 Ensayo inmunologico competitivo utilizando derivados de analitos complejados.

Country Status (8)

Country Link
US (1) US7252961B2 (es)
EP (1) EP0726464B1 (es)
JP (1) JP3502497B2 (es)
AT (1) ATE200353T1 (es)
AU (1) AU4440096A (es)
CA (1) CA2169121C (es)
DE (2) DE19504198A1 (es)
ES (1) ES2156223T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087088A (en) * 1997-01-31 2000-07-11 Bayer Corporation Binding assays using more than one label for determining analyte in the presence of interfering factors
DE10030798A1 (de) * 2000-06-29 2002-01-10 Evotec Analytical Sys Gmbh Kompetitives Assay-Verfahren
GB0027064D0 (en) * 2000-11-06 2000-12-20 Randox Lab Ltd Multi-analyte immunoassay
US20050048876A1 (en) * 2003-09-02 2005-03-03 Applied Materials, Inc. Fabricating and cleaning chamber components having textured surfaces
KR101171253B1 (ko) * 2003-12-24 2012-08-06 신이치로 이소베 생체분자의 검출방법 및 이에 사용하는 표지색소와표지키트
PL2281204T3 (pl) * 2008-04-29 2014-06-30 Psychemedics Corp Wieloanalitowa analiza w fazie stałej dla nadużywanych narkotyków i ich metabolitów
US8084215B2 (en) 2008-04-29 2011-12-27 Psychemedics Corporation Non-proteolytic method for the determination of analytes in keratinized structures

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366143A (en) 1979-09-24 1982-12-28 Amersham International Public Limited Company Assay for the free portion of substances in biological fluids
WO1983003306A1 (en) 1982-03-19 1983-09-29 Roger Philip Ekins Method and composition for free ligand assays
EP0089806B1 (en) * 1982-03-22 1989-06-28 AMERSHAM INTERNATIONAL plc Assay for the free portion of substances in biological fluids
GB8317124D0 (en) * 1983-06-23 1983-07-27 Ekins R P Free ligand assay
DE3442817A1 (de) 1984-11-23 1986-05-28 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und reagenz zur quantitativen bestimmung von freiem thyroxin in plasma, serum oder vollblut
DE3624464A1 (de) 1986-07-19 1988-01-28 Boehringer Mannheim Gmbh Verfahren zum nachweis eines analyten sowie hierfuer geeignetes mittel
DE3727238A1 (de) * 1987-08-14 1989-02-23 Henning Berlin Gmbh Immunologisches bestimmungsverfahren zur bestimmung von hapteneigenschaften aufweisenden freien substanzen
GB8800419D0 (en) * 1988-01-08 1988-02-10 Amersham Int Plc Method for measuring free fraction of ligands in biological fluids
DE3929119A1 (de) * 1989-09-01 1991-03-07 Boehringer Mannheim Gmbh Verfahren zum nachweis von analyten
US5164299A (en) * 1990-03-20 1992-11-17 E. I. Du Pont De Nemours And Company Use of a mixture of conjugated and unconjugated solid phase binding reagent to enhance the performance of assays
US5143852A (en) * 1990-09-14 1992-09-01 Biosite Diagnostics, Inc. Antibodies to ligand analogues and their utility in ligand-receptor assays
IE920778A1 (en) * 1991-03-12 1992-09-23 Du Pont Method for specific binding assays using a releasable ligand
AU2402292A (en) * 1991-07-29 1993-03-02 Serex, Inc. Differential binding affinities and dissociation assays based thereon
US5589344A (en) * 1994-06-15 1996-12-31 Johnson & Johnson Clinical Diagnostics, Inc. Test kit and method for competitive specific binding assay

Also Published As

Publication number Publication date
DE19504198A1 (de) 1996-08-14
EP0726464B1 (de) 2001-04-04
EP0726464A1 (de) 1996-08-14
US20030073126A1 (en) 2003-04-17
ATE200353T1 (de) 2001-04-15
US7252961B2 (en) 2007-08-07
DE59606685D1 (de) 2001-05-10
CA2169121C (en) 2007-07-03
JP3502497B2 (ja) 2004-03-02
CA2169121A1 (en) 1996-08-10
JPH08248029A (ja) 1996-09-27
AU4440096A (en) 1996-08-15

Similar Documents

Publication Publication Date Title
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
EA200300118A1 (ru) Тетрагидропиридино- или пиперидиногетероциклические производные
HN1999000154A (es) 1,2,3,4 tetrahidroquinolinas 2 sustituidas 4 - carboxiamino sustituidas.
HN1997000126A (es) Derivados de indazol
DE69204429D1 (de) Beleuchtungsvorrichtung, insbesondere für Räume ohne Naturlicht.
HN1997000083A (es) Derivados triciclicos sustituidos con fenilamino
PA8527001A1 (es) Poliarilcarboxamidas utiles como agentes reductores de lipidos
CR6935A (es) Agentes del receptor b3-adrenergico y usos de los mismos
TR200000782T2 (tr) Resorsinol türevleri.
UY27098A1 (es) Derivados de indol
CR7728A (es) Nuevas quinazolinas espirocondensadas y su uso como inhibidores de la fosfodiesterasa
ES2175231T3 (es) Nuevas anfetaminas activadas.
ES2175798T3 (es) Cd8 como un inhibidor del sistema inmunitario celular.
ES2156223T3 (es) Ensayo inmunologico competitivo utilizando derivados de analitos complejados.
NL191314C (nl) 3-Monogesubstitueerd-1-azetidine-carboxamidederivaat, alsmede een anticonvulsief preparaat.
ES2169730T3 (es) Patron sintetico para analisis inmunologicos.
BR9916507A (pt) Proteìnas
BR0015872A (pt) Agentes antitrombóticos
EA200100854A1 (ru) Кальций-литические соединения
EA200200435A1 (ru) Анализ лептина
DK1173766T3 (da) Isoform af tenascin-C som markör for neoplasier
ES2172125T3 (es) Procedimiento de fabricacion de un cigueñal.
ES2175899T3 (es) Procedimiento para la preparacion de derivados de piridindicarboxilato.
EA200200798A1 (ru) Кальцилитические соединения
ES2174297T3 (es) Nuevos derivados de piranosidos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 726464

Country of ref document: ES